$Phenotyping of outpatients with heart failure with preserved ejection fraction and poor prognosis$
QR Code

QR Code

Phenotyping of outpatients with heart failure with preserved ejection fraction and poor prognosis

The applicability of the left ventricular global function index (LVGFI) and its derivative, determined by echocardiography, to distinguish clinical phenotypes in a cohort of patients with heart failure with preserved ejection fraction (HFpEF) is unknown.Aim. To evaluate the differential diagnostic...

Full description

Saved in:

Bibliographic Details
Main Authors:	V. N. Larina, V. I. Lunev
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2024-04-01
Series:	Российский кардиологический журнал
Subjects:	heart failure preserved ejection fraction global function index phenotype mortality derived index
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/5759
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Features of phenotyping patients with heart failure with preserved ejection fraction
by: E. K. Serezhina, et al.
Published: (2023-09-01)

Phenotypic clusters in heart failure with preserved and mid-range ejection fraction: new data and perspectives
by: O. V. Tsygankova, et al.
Published: (2021-05-01)

Biomarkers in the Pathogenesis of Heart Failure with Preserved as Well as Reduced Ejection Fraction: A Cross-sectional Study
by: Sowmiya Thiyagarajan, et al.
Published: (2025-06-01)

Prognostic value of secondary hyperaldosteronism in patients with chronic heart failure with preserved ejection fraction
by: A. N. Shevelok
Published: (2021-07-01)

Prognostic Value of the Global Left Ventricular Contractility Index in Patients with Severe Mitral Regurgitation and Preserved Left Ventricular Ejection Fraction
by: Tony Li, et al.
Published: (2025-06-01)

Correlation of β-adrenergic reactivity of erythrocyte membranes with clinical characteristics of patients with coronary artery disease and HF with preserved and reduced ejection fraction
by: E. F. Muslimova, et al.
Published: (2025-01-01)

Predictors of unfavorable progression and prognosis in patients with heart failure with preserved left ventricular ejection fraction
by: M. S. Sobolevskaya, et al.
Published: (2024-12-01)

Markers of heart failure with preserved ejection fraction in patients with unexplained dyspnea
by: A. A. Ivanova, et al.
Published: (2023-11-01)

Molecular biomarker profile of heart failure with mid-range and preserved ejection fraction in patients with type 2 diabetes
by: D. A. Lebedev, et al.
Published: (2020-11-01)

Left atrial stiffness index in the identification of heart failure with preserved ejection fraction
by: N. E. Shirokov, et al.
Published: (2024-05-01)

Prediction model of rehospitalization and mortality in heart failure patients with preserved and mildly reduced ejection fraction: the AD2NNER risk score
by: Flavia-Mihaela Stoiculescu, et al.
Published: (2025-07-01)

Clinical and prognostic value of determining the level of neopterin in patients with chronic heart failure with preserved ejection fraction
by: O. S. Polunina, et al.
Published: (2018-10-01)

Heart failure with preserved left ventricular ejection fraction – clinical perspectives
by: Małgorzata Niemiec, et al.
Published: (2025-07-01)

CHRONIC HEART FAILURE WITH PRESERVED EJECTION FRACTION: TREATMENT IN CONDITIONS OF LIMITED EVIDENCE
by: S. G. KANORSKIĬ, et al.
Published: (2018-10-01)

Beta-blockers in chronic heart failure with preserved left ventricular ejection fraction: is deprescribing possible?
by: V. D. Zakiev, et al.
Published: (2023-12-01)

Low-intensity inflammation as a manifestation of comorbidity and a factor in the unfavorable clinical course of heart failure with preserved ejection fraction
by: K. N. Vitt, et al.
Published: (2024-03-01)

Characteristics of patients with chronic heart failure with mildly reduced ejection fraction: clinical and demographic aspect
by: M. T. Duishenalieva, et al.
Published: (2025-05-01)

Relationship between plasma aldosterone and left ventricular structure and function in patients with heart failure with preserved ejection fraction
by: A. N. Shevelok
Published: (2021-03-01)

Chronic Heart Failure with Preserved Ejection Fraction in A Comorbid Patient: Issues in Verification of A «Difficult» Diagnosis
by: O. V. Ponomareva, et al.
Published: (2025-05-01)

Heat shock proteins in the assessment of the course and prognosis of heart failure with preserved ejection fraction
by: Yu. S. Timofeev, et al.
Published: (2025-05-01)

Prognostic significance of NT-proBNP and sST2 in patients with heart failure with preserved and mildly reduced ejection fraction
by: V. I. Podzolkov, et al.
Published: (2023-10-01)

Prognostic value of myocardial flow reserve in patients with heart failure with preserved ejection fraction
by: K. V. Kopeva, et al.
Published: (2023-04-01)

Significance of catestatin in the pathogenesis of heart failure with preserved ejection fraction in patients with non-obstructive coronary artery disease
by: E. V. Grakova, et al.
Published: (2023-11-01)

The impact of glomerular filtration rate on short-term outcome in elderly patients with heart failure with preserved ejection fraction
by: Giuseppe Delli Carpini, et al.
Published: (2025-07-01)

Prevalence and echocardiographic predictors of atrial fibrillation in patients with heart failure with preserved ejection fraction
by: K. G. Adamyan, et al.
Published: (2016-02-01)

Novel algorithms for diagnosing heart failure with preserved ejection fraction in patients with hypertension and obesity
by: Yu. A. Vasyuk, et al.
Published: (2021-02-01)

Left atrial strain in assessing heart failure with preserved ejection fraction in hypertensive patients
by: E. S. Mazur, et al.
Published: (2022-09-01)

Relationship between gut microbiota and markers of myocardial fibrosis in with chronic heart failure with preserved ejection fraction
by: A. N. Kaburova, et al.
Published: (2021-07-01)

The Value of Biomarkers in the Diagnosis and Prognosis of Heart Failure in Older Age
by: V. N. Larina, et al.
Published: (2021-03-01)

Chatterjee phenomenon in a patient with heart failure with preserved ejection fraction: a case report
by: K. N. Vitt, et al.
Published: (2023-04-01)

Dynamics of Vascular Stiffness and Endothelial Function in Combination Therapy of Heart Failure with Preserved Ejection Fraction
by: Z. M. Akhilgova, et al.
Published: (2020-07-01)

The relationship between gut microbiota, chronic systemic inflammation, and endotoxemia in patients with heart failure with preserved ejection fraction
by: A. N. Kaburova, et al.
Published: (2022-10-01)

Analysis of echocardiographic parameters suggestive of pulmonary hypertension in patients with heart failure with preserved ejection fraction and assessment of clinical features favoring development of the PH-phenotype
by: Julia Dołęga, et al.
Published: (2025-04-01)

Heart failure with preserved ejection fraction in patients with type 2 diabetes mellitus: pathophysiology and treatment options
by: A. A. Borisov, et al.
Published: (2021-07-01)

Role of humoral markers in the pathogenesis of heart failure with preserved ejection fraction in patients with non-obstructive coronary artery disease
by: E. V. Grakova, et al.
Published: (2022-11-01)

Effect of combination antihypertensive therapy, including renin-angiotensin-aldosterone system inhibitors, on oxidative stress and arterial remodeling in hypertensive patients with heart failure with preserved ejection fraction
by: Z. M. Akhilgova, et al.
Published: (2021-06-01)

Association Between Hyperaldosteronemia and Electrophysiological Myocardial Activity in Heart Failure with Preserved Ejection Fraction
by: A. N. Shevelok
Published: (2020-10-01)

Heart failure with preserved ejection fraction: the role of microvascular dysfunction
by: K. V. Kopeva, et al.
Published: (2023-01-01)

Diagnostic challenges of heart failure with preserved ejection fraction: focus on echocardiography
by: A. A. Ivanova, et al.
Published: (2023-06-01)

NEW EMPHASES ON THE STUDY OF THE PATHOGENESIS OF CHRONIC HEART FAILURE WITH PRESERVED EJECTION FRACTION: FOCUS ON INFLAMMATORY MARKERS
by: O. M. Drapkina, et al.
Published: (2015-09-01)